Client Login Pay My Bill

Publications

Studies, White Papers, and Conferences

Studies & Findings

View studies and summary reports.

Novel Psychoactive Substances Testing

Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine

Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens

Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples

Drug-Drug Interaction Testing

Impact of Medication Nonadherence and Drug-Drug Interaction Testing on the Management of Primary Care Patients with Polypharmacy: a Randomized Controlled Trial

Chronic Disease Management

Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians

Randomized Prospective Trial to Detect and Distinguish Between Medication Nonadherence, Drug-Drug Interactions, and Disease Progression in Chronic Cardiometabolic Disease

Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results

Infectious Disease Testing

National Surveillence of COVID-19 Infections:Variants, Vaccination Status, and Viral Spread

Evaluation of an Optimized Protocol and Illumina ARTIC V4 Primer Pool for Sequencing of SARS-CoV-2 Using COVIDSeq™ and DRAGEN™ COVID LineageApp Workflow

Scaling a High Throughput Next Generation Sequencing Laboratory for Community Surveillance of Sars-Cov-2 Viral Variants During the Public Health Crisis

Top Rated Abstract When Reviewed by the ACMG Annual Clinical Genetics Meeting Program Committee: Tracking the Emergence of Sars-Cov-2 Variants of Concern in Vaccinated and Unvaccinated Patients

Estimated BNT162b2 Vaccine Effectiveness Against Infection with Delta and Omicron Variants Among US Children 5 to 11 Years of Age

Validation of Reduced S-gene Target Performance and Failure for Rapid Surveillance of SARS-CoV-2 Variants

Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023

White Papers

Learn more by clicking the links below.

Synthetic Substitution: Identifying Non-Urine Substances Amidst Medication Compliance Testing

Next Generation Sequencing: Monitoring Change during the COVID-19 Pandemic

Capturing the Truth – Quality-Driven Laboratory Results to Improve Patient Outcomes

Assisting a Community at a Crossroads: Tools to Support the Fight in the Ongoing Opioid Epidemic

Scientific Research

View Poster Presentations.

Nitazene Analogs – Ongoing Evaluation of an Emerging Threat

Buprenorphine Co-positivity with Designer Benzodiazepines in Routine Healthcare Urine Samples

Designer Benzodiazepine Positivity and Co-Positivity in Urine Specimens Received December 2020 to April 2021

Scaling a High Throughput Next Generation Sequencing Laboratory for Community Surveillance of Sars-Cov-2 Viral Variants During the Public Health Crisis

Evaluating Methodologies for Monitoring Designer Drug Exposure and a Comparison of Results

Oral Fluid as a Viable Matrix for Detecting Drug-Drug Interactions

Detection of Eutylone in Chronic Pain and Behavioral Health Populations